Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

LAM Research Corp (LRCX.O)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2022-02-2255.9776.00Buy
2022-04-1147.5857.50Buy
2022-04-2048.1556.00Buy
2022-06-2843.8351.00Buy
2022-07-2848.4953.00Buy
2022-10-0737.4849.50Buy
2022-10-1334.0645.00Buy
2022-11-2944.2153.00Buy
2023-02-2147.8358.00Buy
2023-04-1650.0857.50Buy
2023-05-3063.0072.50Buy
2023-07-2770.2075.00Buy
2023-10-0562.5872.50Buy
2023-12-1577.3588.50Buy
2024-03-0497.75113.00Buy
2024-04-2590.15115.00Buy
2024-07-15106.91130.00Buy
2024-08-0183.03125.00Buy
2024-09-1274.78115.00Buy
2024-10-2476.57105.00Buy
2025-01-3080.73100.00Buy
2025-03-1073.8195.00Buy
2025-04-1467.8690.00Buy
2025-04-2470.9095.00Buy

Disclosures

  • The equity analyst covering this company, a member of his or her team, or one of their household members has a long common stock position in this company.
  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.